L.N. 325 of 2006 MEDICINES ACT (CAP. 458) Medicinal Products (Package Leaflets and Labelling) (Transitional Arrangements) Regulations, 2006

These regulations address temporary measures for the labelling and package leaflets of medicinal products. They ensure continued compliance during a transition period, likely related to updated EU directives or national laws. This affects pharmaceutical companies, healthcare providers, and ultimately patients by ensuring clear and accurate information on medicines.